What is the Impact Factor of Therapeutic Advances in Hematology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Therapeutic Advances in Hematology is 2.80, ranking in quartile Q2 of Web of Science (SCIE).

Is Therapeutic Advances in Hematology indexed in Web of Science or Scopus?

Yes, Therapeutic Advances in Hematology is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.018 (Q1) and an H-index of 41.

Who publishes Therapeutic Advances in Hematology and what is the Article Processing Charge (APC)?

Therapeutic Advances in Hematology is published by SAGE PUBLICATIONS LTD. The estimated Article Processing Charge (APC) is approximately $3,317 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Therapeutic Advances in Hematology?

The official ISO-4 abbreviation of Therapeutic Advances in Hematology is "THER ADV HEMATOL". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #4,776Top JournalReview JournalGold OA

Therapeutic Advances in Hematology

Abbreviation (ISO):THER ADV HEMATOL

•

Identifier (ISSN):2040-6207(Print)/2040-6215(Online)

•

Publisher:SAGE PUBLICATIONS LTD

Official Website Submission Portal Compare

Clarivate IF (2026)

2.8↓ -0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Therapeutic Advances in Hematology

WoS Q2

Annual Impact Factor Metric

Current (2026):2.8

Scopus SJR & RankScopus Q1

1.018

#4,776

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

41 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

54articles/year

100% Gold OA•57.81% Original Research

Aims & Scope

Therapeutic Advances in Hematology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of hematology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in hematology, providing a forum in print and online for publishing the highest quality articles in this area.

Topics Covered (Recognized by AI)

Medicine99.6%Internal medicine96.9%Biology92.7%Genetics84.5%Immunology82.3%Pathology71.9%Surgery58.6%Oncology51.8%Chemistry49.8%Biochemistry45.1%Cell biology36.5%Cancer research33.2%Antibody29.2%Leukemia28.8%Chemotherapy28.5%Disease27.7%Lymphoma27.4%Cancer22.8%Bioinformatics22.6%Transplantation22.3%Stem cell22.1%Gene21.5%Psychology20.6%

Primary Research Areas

Hematology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

HEMATOLOGY

Rank42/103

IndexSCIE

JCISCIE2026

HEMATOLOGY

Rank42/103

IndexSCIE

Category	Index	Rank	Quartile
HEMATOLOGY	JCRSCIE	42/103	Q2
HEMATOLOGY	JCISCIE	42/103	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.8

Articles / Year46

Total Citations15

2025

IF3.1

Articles / Year61

Total Citations103

2024

IF3.4

Articles / Year65

Total Citations284

2023

IF3.4

Articles / Year51

Total Citations481

2022

IF5.4

Articles / Year60

Total Citations946

Year	Impact Factor	Articles / Year	Total Citations
2026	2.8	46	15
2025	3.1	61	103
2024	3.4	65	284
2023	3.4	51	481
2022	5.4	60	946
2021	7.167	65	1,048
2020	3.456	55	1,244
2019	3.105	34	1,729
2018	0	23	743
2017	—	24	669
2016	—	33	1,042
2015	—	30	1,158

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,776Scopus Q1SCImago Profile

Scopus Coverage:2010-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

1.018

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

2.63

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,317 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations524

3-Year Documents175

Citable Documents170

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区HEMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Therapeutic Advances in Hematology (abbr: THER ADV HEMATOL, ISSN: 2040-6207) is a peer-reviewed international scholarly journal in the field of HEMATOLOGY, published by SAGE PUBLICATIONS LTD in United States. The periodical holds a Journal Impact Factor (JIF) of 2.80, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.018 (Q1), an H-index of 41.

The journal enforces rigorous peer evaluation with an annual output of approximately 54 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,317 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.